Miami Cancer Institute publication analyzes r

<p>Researchers from Miami Cancer Institute, part of Baptist Health South Florida, today published a study in <em>Trends in Cancer</em> that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs).</p>

Related Keywords

Boston ,Massachusetts ,United States ,Florida ,Florida Keys ,Miami ,America ,Manmeets Ahluwalia ,Atulyaa Khosla ,Vivek Subbiah ,Bayer Incyte ,Eli Lilly ,Ahmad Ozair ,Roche Genentech ,Caris Lifesciences ,Mohamed Gouda ,Fernandez Family Foundation ,Boston Pharmaceuticals ,Varian Medical Systems ,Idera Pharmaceuticals Incyte ,National Comprehensive Cancer Network ,Miami Cancer Institute ,Pfizer ,Baptist Health South Florida ,Glaxosmithkline ,Novartis ,Method Of Research ,Md Anderson Cancer Center ,Medinnovate Advisors ,Cancer Research At Miami Institute ,Amgen ,Astrazeneca ,Fujifilm ,Baptist Health Cancer Care ,Fernandez Family Foundation Endowed Chair ,Cancer Research ,Cancer Institute ,South Florida ,Latin America ,Memorial Sloan Kettering Cancer ,Voyager Therapeutics ,Pyramid Biosciences ,Cairn Therapeutics ,Anheart Therapeutics ,Scientific Advisory Board ,Blueprint Medicines ,Boston Biomedical ,Dragonfly Therapeutics ,Idera Pharmaceuticals ,Loxo Oncology ,Relay Therapeutics ,Turning Point Therapeutics ,Cancer Center ,Helsinn Healthcare ,